Transaction · 0001366268-26-000009

Kayyem Jon Faiz

Kayyem Jon Faiz, DIR, reported a transaction classified as grant at Inhibrx Biosciences, Inc. involving 10000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 10000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
INBXInhibrx Biosciences, Inc.
Trade date
Jun 03, 2026
Filing date
Sep 18, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded10.0k$0.00 per share
Holdings after10.0kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 107 calendar days after the transaction date.

INBX price since this filing

Daily closing prices, with the filing date and available return windows
INBX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -8.9%30d -17.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001366268-26-000009
Stock Option (right to buy)
Transaction date
Jun 03, 2026
Filed Sep 18, 2026, 08:20 PM · 107d delay
Shares
10,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
10,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Amended Filing Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-22 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • amended_filing-6 points

    is_amendment = true

    Amended filing: the original transaction may have been restated.
  • delayed_filing-6 points

    reporting_delay_days = 107

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date.

Amended filing · 0001366268-26-000009
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

INBX